Abbott Laboratories (ABT)

107.62 +0.76 (+0.72%) USD  |  NYSE  |  Apr 26, 15:55
More

Abbott Laboratories Research and Development Expense (TTM): 2.771B for March 31, 2024

Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 1994. Upgrade now.
Date Value
March 31, 2024 2.771B
December 31, 2023 2.741B
September 30, 2023 2.766B
June 30, 2023 2.876B
March 31, 2023 2.845B
December 31, 2022 2.888B
September 30, 2022 2.925B
June 30, 2022 2.815B
March 31, 2022 2.785B
December 31, 2021 2.742B
September 30, 2021 2.678B
June 30, 2021 2.586B
March 31, 2021 2.496B
December 31, 2020 2.42B
September 30, 2020 2.317B
June 30, 2020 2.333B
March 31, 2020 2.346B
December 31, 2019 2.44B
September 30, 2019 2.407B
June 30, 2019 2.385B
March 31, 2019 2.383B
December 31, 2018 2.30B
September 30, 2018 2.357B
June 30, 2018 2.351B
March 31, 2018 2.296B
Date Value
December 31, 2017 2.26B
September 30, 2017 2.009B
June 30, 2017 1.793B
March 31, 2017 1.621B
December 31, 2016 1.447B
September 30, 2016 1.448B
June 30, 2016 1.474B
March 31, 2016 1.471B
December 31, 2015 1.405B
September 30, 2015 1.397B
June 30, 2015 1.324B
March 31, 2015 1.289B
December 31, 2014 1.345B
September 30, 2014 1.343B
June 30, 2014 1.377B
March 31, 2014 1.43B
December 31, 2013 1.407B
September 30, 2013 1.425B
June 30, 2013 1.437B
March 31, 2013 1.444B
December 31, 2012 1.462B
September 30, 2012 -380.84M
June 30, 2012 278.14M
March 31, 2012 945.31M
December 31, 2011 1.512B

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

2.317B
Minimum
Sep 2020
2.925B
Maximum
Sep 2022
2.628B
Average
2.710B
Median

Research and Development Expense (TTM) Benchmarks

Boston Scientific Corp 1.415B
Stryker Corp 1.388B
Intuitive Surgical Inc 1.038B
Insulet Corp 205.00M
Edwards Lifesciences Corp 1.072B